Cortrosin injection 0.25mg, manufactured by Alfresa Pharma, contains tetracosyctide acetate. This medication is a synthetic adrenocorticotropic hormone (ACTH) analogue used for diagnostic purposes to assess adrenal cortical function. It is provided as 0.25mg x 1 bottle (with dissolving solution) with YJ code 2411400D2029.
Cortrosin injection 0.25mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).